News on menopausal hormone therapy
- Authors: Demidova T.Y.1, Zenina S.G2, Gasanzade P.A2
-
Affiliations:
- N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 4 (2018)
- Pages: 47-51
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95018
- DOI: https://doi.org/10.26442/2075-1753_2018.4.47-51
- ID: 95018
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T. Yu Demidova
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: t.y.demidova@gmail.com
д-р мед. наук, проф., зав. каф. эндокринологии лечебного фак-та 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
S. G Zenina
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federationврач-ординатор каф. эндокринологии 123995, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1 *t.y.demidova@gmail.com
P. A Gasanzade
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federationврач-ординатор каф. эндокринологии 123995, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1 *t.y.demidova@gmail.com
References
- Harlow S.D, Gass M, Hall J.E et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012; 15 (2): 105-14.
- Rossouw J.E, Anderson G.L, Prentice R.L et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
- Rossouw J.E, Prentice R.L, Manson J.E et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-77.
- Cobin R.H, Goodman N.F et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on menopause-2017 Update. Endocrine Practice 2017; 23 (7): 869-79.
- Santen R.J, Allred D.C, Ardoin S.P et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010; 95: s1-s66.
- Maclennan A.H, Broadbent J.L, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004; 4: CD002978.
- Stuenkel C.A, Davis S.R, Gompel A et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015; 100 (11): 3975-4011.
- Shao H, Breitner J.C, Whitmer R.A et al. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 2012; 79: 1846-52.
- Manson J.E, Chlebowski R.T, Stefanick M.L et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013; 310: 1353-68.
- National Osteoporosis Foundation. 2014 Clinician’s Guide to Prevention and Treatment of Osteoporosis. http://nof.org/files/nof/public/content/file/2791/upload/919.pdf
- Boardman H.M, Hartley L, Eisinga A et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015; 3: CD002229.
- Files J.A, Ko M.G, Pruthi S. Bioidentical hormone therapy. Mayo Clin Proc 2011; 86: 673-80.